CARRICK THERAPEUTICS
Carrick Therapeutics is a developer of cancer therapeutics intended to transform the way cancer is treated. The company's therapeutics target molecular pathways that drive the most aggressive and resistant forms of cancer using innovative mechanisms, enabling cancer patients to get their predictive biomarkers detected and get their treatments started from early stage.
CARRICK THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2015-01-01
Address:
Dublin, Dublin, Ireland
Country:
Ireland
Website Url:
http://www.carricktherapeutics.com
Total Employee:
51+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
95 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics WordPress Google Universal Analytics Apache Wordpress Plugins Mobile Non Scaleable Content Sitelinks Search Box
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Amyloid Solution
Amyloid Solution is a developer of therapy intended to overcome Alzheimer by developing modifying treatments.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Exciva
German company is a provider of targeted drug rescue program intended to involve pharmaceutical research and development.
โOxford Vacmedix
Develop therapeutic agents for the treatment of cancer .
Phico Therapeutics
Phico Therapeutics is a developer of novel platform technology designed to overcome antibacterial resistance.
PolyProx
PolyProx Therapeutics is a developer of a novel class of drug intended to provide new therapies for cancer treatment.
Rainier Therapeutics
Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.
Rodeo Therapeutics
Rodeo Therapeutics is a developer of small-molecule therapies designed to promote regeneration and repair of multiple tissue types.
Spiraldynamik
Spiraldynamik is an anatomically based movement and therapy concept, an instruction manual for the own body from head to toe.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Cambridge Innovation Capital
Cambridge Innovation Capital investment in Series A - Carrick Therapeutics
Woodford Investment Management
Woodford Investment Management investment in Series A - Carrick Therapeutics
ARCH Venture Partners
ARCH Venture Partners investment in Series A - Carrick Therapeutics
Evotec
Evotec investment in Series A - Carrick Therapeutics
University of Cambridge Enterprise
University of Cambridge Enterprise investment in Series A - Carrick Therapeutics
Lightstone Ventures
Lightstone Ventures investment in Series A - Carrick Therapeutics
GV
GV investment in Series A - Carrick Therapeutics
Official Site Inspections
http://www.carricktherapeutics.com
- Host name: ec2-174-129-30-187.compute-1.amazonaws.com
- IP address: 174.129.30.187
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Carrick Therapeutics"
About - Carrick Therapeutics, Inc.
Building a solid foundation for novel cancer therapies. Carrick Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel therapies for aggressive and resistant forms of cancer.See details»
Carrick Therapeutics - Crunchbase Company Profile
Contact Email [email protected] Carrick Therapeutics is a developer of cancer therapeutics intended to transform the way cancer is treated. The company's therapeutics target molecular pathways that drive the most โฆSee details»
Management Team - Carrick Therapeutics, Inc.
Dr. Bahl has 25 years of international Pharmaceutical experience leading collaborations in US, Japan, and Europe. His previous roles were with Eli Lilly (Vice President of External โฆSee details»
Carrick Therapeutics Company Profile 2025: Valuation, โฆ
Carrick Therapeutics General Information Description. Developer of cancer therapeutics designed to change the cancer patients treatment and the lives. The company's therapeutics target molecular pathways that drive away aggressive โฆSee details»
Carrick Therapeutics - LinkedIn
Carrick Therapeutics is pioneering a portfolio of unique, first in class, cancer treatments that target driver mechanisms of the most aggressive forms of cancer, and which will be tailored to an ...See details»
Carrick Therapeutics Company Profile | Management and
Www.carricktherapeutics.com Carrick Therapeutics Profile and History Carrick Therapeutics was founded in 2016, it has a clear vision for cancer patients: to target the molecular pathways that โฆSee details»
Carrick Therapeutics - LinkedIn
Carrick Therapeutics | 2,206 followers on LinkedIn. Transformative Cancer Medicines | Carrick Therapeutics is pioneering a portfolio of unique, first in class, cancer treatments that target โฆSee details»
Creating a premier oncology biotech company in Europe - Nature
Carrick Therapeutics. Elaine Sullivan, CEO, Carrick Therapeutics, Dublin, Ireland, Tel: +353 1 716 3620, Website: www.carricktherapeutics.comSee details»
Carrick Therapeutics (Ireland) Funding: $155M - Medical Startups
Dec 10, 2024 Transforming cancer treatments and the lives of cancer patients by targeting the molecular pathways that drive the most aggressive and resistant forms of...See details»
Company Information :: Carrick Therapeutics, Inc.
Contact Information. Email Alerts; Company Profile; Contacts; RSS News Feed; 2024 Carrick Therapeutics, Inc. All Rights Reserved.See details»
Carrick Therapeutics - Company Profile & Staff Directory
Carrick Therapeutics is pioneering a portfolio of unique, first in class, cancer treatments that target driver mechanisms of the most aggressive forms of cancer, and which will be tailored to an โฆSee details»
Carrick Therapeutics - Craft
Carrick Therapeutics has 5 employees across 2 locations and $95 m in total funding,. See insights on Carrick Therapeutics including office locations, competitors, revenue, financials, โฆSee details»
Carrick Therapeutics - Seedtable
Carrick Therapeutics, based in Dublin, shows strong potential due to its focus on innovative therapies for difficult-to-treat diseases. As a clinical-stage biopharmaceutical company, Carrick โฆSee details»
Carrick Therapeutics - Overview, News & Similar companies
Dec 18, 2022 Who is Carrick Therapeutics. Carrick Therapeutics was founded in 2016, it has a clear vision for cancer patients: to target the molecular pathways that drive the most aggressiv โฆSee details»
Carrick Therapeutics Company Overview, Contact Details
Carrick Therapeutics. Biotechnology Research Dublin, Ireland 11-50 Employees. Carrick Therapeutics is pioneering a portfolio of unique, first in class, cancer treatments that target โฆSee details»
Carrick Therapeutics Announces $35 Million Investment from Pfizer
Dec 1, 2022 DUBLIN, Ireland and BOSTON, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Carrick Therapeutics, an oncology-focused biopharmaceutical company discovering and developing โฆSee details»
Investors - Carrick Therapeutics, Inc.
Sep 23, 2024 Email Alerts. Stay informed and receive company updates straight to your inbox. Sign up todaySee details»
Carrick Therapeutics Ltd. (Carrick Therapeutics Ltd.) - ่ฏ็ฉ็ฎก็บฟ_ไธ โฆ
For additional information on the clinical trial, please contact [email protected]. About Vepdegestrant (ARV-471) Vepdegestrant is an investigational, orally bioavailable โฆSee details»
Katalin Karikóโs Nobel PrizeโWinning Work on mRNA Was Long โฆ
2 days ago More recently she worked for Transparency International, the anti-corruption organization, and strategy+business magazine. More by Deborah Unger Gabriela Saldivia is a โฆSee details»
Science :: Carrick Therapeutics, Inc.
Science that's driven by patient outcomes. Current oncology therapies, particularly in late-stage disease, are often limited in their effectiveness, and as such, there is a large un-met need in โฆSee details»